PATENT CLAIM ANALYSIS

Application Number: 16249884
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "561000"]

Abstract:
The present invention provides a pharmaceutical composition comprising an aqueous solution of an ibuprofen solubilizing agent and ibuprofen, the ibuprofen solubilizing agent being in an effective amount such that the ibuprofen in the solution remains soluble at concentrations from 100 mg/mL to 5 mg/mL without undergoing a phase transition. The invention further provides a method of treating a condition chosen from pain, inflammation, fever, and/or patent ductus arteriosis, comprising administering to a patient in need thereof an effective amount of an aqueous solution a ibuprofen solubilizing agent and ibuprofen, the ibuprofen solubilizing agent being in an effective amount such that the ibuprofen in the solution remains soluble at concentrations from 100 mg/mL to 5 mg/mL without undergoing a phase transition, as well as a method for manufacturing the composition.

Claim (Index 52):
The pharmaceutical composition of  claim 45 , which remains clear and colorless when stored for at least 12 weeks at 75\u00b0 C.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 99.0
- Lexical Diversity: 2.37931
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13422761', '13422738', '14538464', '13278703', '12646499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7897194781985181
- 35 USC 102 Novelty (BERT): 0.553445951959537
- Combined Prediction Score: 0.7660921255746199
- Mean Citation Score: 295.6457460000001
- Max Citation Score: 439.2788
- Similarity Product: 294.1112139690161

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test